Back to People
Dan Moore
Founding Partner
New York
dan@collectedstrategies.com

Dan Moore has been a strategic communications advisor for nearly two decades, during which time he has counseled hundreds of companies around proxy fights, transactions and restructurings, as well as ongoing reputation management, investor and media relations. Select mandates over the years include Box in its proxy fight win against Starboard Value, 3M in its separation of its healthcare business, Teva Pharmaceuticals in its unsolicited proposal to acquire Mylan and in its acquisition of Allergan Generics, among many other event-driven and crisis assignments. Dan thrives in the intense, high-profile situations that change the fabric of companies and their leadership teams. He started his career at FTI Consulting in the special situations and strategy consulting practices. He is a member of the National Investor Relations Institute (NIRI) and was named to NIRI’s Rising Leaders Under 40. He was a partner at Joele Frank until 2023.

Recent & Notable Assignments
  • Ambrx in its $2 billion sale to Johnson & Johnson
  • NEXTracker in its $119 million acquisition of Ojio Inc.
  • Uphealth in its $180 million sale of Cloudbreak to GTCR
  • Curo Group in its Chapter 11 restructuring
  • Admiral Acquisition in its $1.85 billion acquisition of ASP Acuren Holdings
  • Vanda Pharmaceuticals in its defense of an unsolicited acquisition proposal from Future Pak
  • APi Group in its $570 million acquisition of Elevated Facility Services Group
  • ContextLogic in the divestiture of the Wish brand business
  • MDC Holdings in its $4.9 billion sale to Sekisui House Ltd.
  • Star Bulk Carriers in its $610 million acquisition of Eagle Bulk Shipping
  • Vice Media in its Chapter 11 restructuring
  • David's Bridal in its Chapter 11 restructuring
  • Box in its successful proxy contest against Starboard Value
Areas of Expertise
  • Shareholder Activism
  • Mergers & Acquisitions
  • Investor Relations
  • Restructuring
  • Media Relations
  • Industrials
  • Aerospace
  • Energy
  • Utilities
  • Pharmaceuticals & Biotech
  • Healthcare & MedTech
  • Media & Entertainment